JP2007302683A5 - - Google Patents

Download PDF

Info

Publication number
JP2007302683A5
JP2007302683A5 JP2007180722A JP2007180722A JP2007302683A5 JP 2007302683 A5 JP2007302683 A5 JP 2007302683A5 JP 2007180722 A JP2007180722 A JP 2007180722A JP 2007180722 A JP2007180722 A JP 2007180722A JP 2007302683 A5 JP2007302683 A5 JP 2007302683A5
Authority
JP
Japan
Prior art keywords
solution
homogeneous dispersion
expanding
boiling
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007180722A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007302683A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2007302683A publication Critical patent/JP2007302683A/ja
Publication of JP2007302683A5 publication Critical patent/JP2007302683A5/ja
Pending legal-status Critical Current

Links

JP2007180722A 2000-06-27 2007-07-10 組成物の調製方法 Pending JP2007302683A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00113535 2000-06-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002504983A Division JP4149803B2 (ja) 2000-06-27 2001-06-18 組成物の調製方法

Publications (2)

Publication Number Publication Date
JP2007302683A JP2007302683A (ja) 2007-11-22
JP2007302683A5 true JP2007302683A5 (OSRAM) 2008-07-31

Family

ID=8169074

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002504983A Expired - Lifetime JP4149803B2 (ja) 2000-06-27 2001-06-18 組成物の調製方法
JP2007180722A Pending JP2007302683A (ja) 2000-06-27 2007-07-10 組成物の調製方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002504983A Expired - Lifetime JP4149803B2 (ja) 2000-06-27 2001-06-18 組成物の調製方法

Country Status (37)

Country Link
US (3) US6534087B2 (OSRAM)
EP (1) EP1296656B1 (OSRAM)
JP (2) JP4149803B2 (OSRAM)
KR (1) KR100557845B1 (OSRAM)
CN (1) CN1236764C (OSRAM)
AR (1) AR029278A1 (OSRAM)
AT (1) ATE334662T1 (OSRAM)
AU (2) AU2001281846B2 (OSRAM)
BR (1) BRPI0112014B1 (OSRAM)
CA (1) CA2411153C (OSRAM)
CY (1) CY1105714T1 (OSRAM)
CZ (1) CZ301813B6 (OSRAM)
DE (1) DE60121953T2 (OSRAM)
DK (1) DK1296656T3 (OSRAM)
EC (1) ECSP024401A (OSRAM)
EG (1) EG24141A (OSRAM)
ES (1) ES2269441T3 (OSRAM)
HR (1) HRP20021009B1 (OSRAM)
HU (1) HU229550B1 (OSRAM)
IL (2) IL153282A0 (OSRAM)
JO (1) JO2247B1 (OSRAM)
MA (1) MA26922A1 (OSRAM)
ME (1) MEP90608A (OSRAM)
MX (1) MXPA02012583A (OSRAM)
MY (1) MY129798A (OSRAM)
NO (1) NO332181B1 (OSRAM)
NZ (1) NZ523024A (OSRAM)
PE (1) PE20020101A1 (OSRAM)
PL (1) PL203804B1 (OSRAM)
PT (1) PT1296656E (OSRAM)
RU (1) RU2244542C2 (OSRAM)
SI (1) SI1296656T1 (OSRAM)
TW (1) TWI278325B (OSRAM)
UY (1) UY26799A1 (OSRAM)
WO (1) WO2002000201A2 (OSRAM)
YU (1) YU96602A (OSRAM)
ZA (1) ZA200209649B (OSRAM)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
IL153282A0 (en) * 2000-06-27 2003-07-06 Hoffmann La Roche Method for preparing a pharmaceutical composition
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
DE60330764D1 (de) 2002-04-26 2010-02-11 Hoffmann La Roche Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan
KR100517072B1 (ko) * 2002-11-25 2005-09-26 주식회사 태평양 폴리올/고분자 마이크로캡슐 및 이를 이용한 효소 안정화방법
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
WO2005055921A2 (en) * 2003-12-12 2005-06-23 Eran Eilat Compositions for treatment of ear disorders and methods of use thereof
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
AU2005244329A1 (en) * 2004-04-06 2005-11-24 Rpg Life Sciences Limited Mouth dissolvable and meltable, and water dispersable delivery formulation
CA2579500A1 (en) * 2004-09-15 2006-03-23 Banyu Pharmaceutical Co., Ltd. Sampling method and sampling device, and logd measuring method and logd measuring system
EP1837032A4 (en) * 2004-12-31 2009-06-10 Mikhail Yurievich Gotovsky MAGNETIC RESONANCE PREPARATIONS AND DEVICE FOR INDIVIDUALLY SELECTING SUCH PREPARATIONS TO INCREASE THE ACTIVITY OF AN ORGANISM UNDER CURRENT ENVIRONMENTAL CONDITIONS
US20060198856A1 (en) * 2005-03-01 2006-09-07 Keith Whitehead Ibuprofen suspension stabilized with docusate sodium
WO2006110809A2 (en) * 2005-04-12 2006-10-19 Elan Pharma International, Limited Nanoparticulate lipase inhibitor formulations
US7984717B2 (en) * 2005-04-29 2011-07-26 Medtronic, Inc. Devices for augmentation of lumen walls
US20070060610A1 (en) * 2005-06-16 2007-03-15 Wempe Michael F Methods and pharmaceutical formulations for increasing bioavailability
WO2006136196A1 (en) * 2005-06-21 2006-12-28 V. Mane Fils Gellan seamless breakable capsule and process for manufacturing thereof
WO2006136197A1 (en) 2005-06-21 2006-12-28 V. Mane Fils Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
KR100669497B1 (ko) * 2005-08-17 2007-01-16 보람제약주식회사 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
WO2007046102A2 (en) 2005-10-19 2007-04-26 Menni Menashe Zinger Methods for the treatment of hyperhidrosis
WO2007079147A2 (en) 2005-12-28 2007-07-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
FR2895908B1 (fr) * 2006-01-12 2008-03-28 France Etat Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir
KR20080097468A (ko) 2006-02-20 2008-11-05 추가이 세이야쿠 가부시키가이샤 인산 오셀타미비어 함유 의약 조성물
US7903256B2 (en) 2006-03-16 2011-03-08 Duke University Methods, systems, and computer program products for performing real-time quadrature projection based Fourier domain optical coherence tomography
CN1820744B (zh) * 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
EP1872777A1 (en) * 2006-06-27 2008-01-02 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising tetrahydrolipstatin
KR100812824B1 (ko) 2006-09-27 2008-03-12 주식회사 제닉 키토산과 폴리에틸렌글리콜을 이용한 생체친화성 저독성필름
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
KR20100020008A (ko) * 2007-05-18 2010-02-19 티티아이 엘뷰 가부시키가이샤 생물학적 인터페이스를 통한 활성 성분의 방출을 개선한 경피 전달 장치
KR101439470B1 (ko) * 2007-05-22 2014-09-16 한미사이언스 주식회사 오를리스타트 및 대변 연화제를 포함하는 비만의 예방 또는치료용 조성물
EP2219614A1 (en) * 2007-10-15 2010-08-25 Inventis DDS Pvt Limited Pharmaceutical composition of orlistat
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
GB0900551D0 (en) 2009-01-14 2009-02-11 Horton Richard Ingestible compositions and processes of preparation
EP2410996B1 (en) 2009-03-27 2017-08-02 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
PL2435554T3 (pl) 2009-05-26 2018-01-31 Advanced Bionutrition Corp Stabilna kompozycja suchego proszku zawierająca biologicznie aktywne mikroorganizmy i/lub materiały bioaktywne i sposoby jej wykonania
WO2011040956A1 (en) * 2009-09-29 2011-04-07 Michael Burnet Novel pesticide formulations
KR100940745B1 (ko) * 2009-10-15 2010-02-04 광동제약 주식회사 오를리스타트 및 아타풀지트 함유 복합제의 코팅펠렛 및 이를 이용한 제제
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CA2785815C (en) 2010-01-28 2018-04-24 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
KR101021030B1 (ko) * 2010-03-25 2011-03-09 엘지이노텍 주식회사 형광체 코팅방법, 발광장치 제조방법 및 코팅된 형광체
KR101800773B1 (ko) * 2010-04-07 2017-11-23 미쯔비시 가스 케미칼 컴파니, 인코포레이티드 보존안정성이 우수한 ｓ-아데노실-ｌ-메티오닌 함유 건조 효모 조성물 및 그 제조 방법
PH12013500272B1 (en) 2010-08-13 2019-07-03 Advanced Bionutrition Corp Dry storage stabilizing composition for biological materials
CA2816119C (en) * 2010-10-29 2019-03-05 Western University Of Health Sciences Ternary mixture formulations
PL2680815T3 (pl) 2011-03-01 2017-02-28 The Procter & Gamble Company Porowate, ulegające rozpadowi stałe podłoże do zastosowań związanych z higieną osobistą
WO2013142792A1 (en) 2012-03-23 2013-09-26 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CN103222964B (zh) * 2013-01-29 2014-10-08 青岛大学 一种奥利司他口服制剂及其制备方法
GB2524496A (en) * 2014-03-24 2015-09-30 British Airways Plc Dynamic tracking and control of passenger travel progress
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
EP3314007B1 (en) 2015-06-25 2024-01-24 Native Microbials, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
WO2018126026A1 (en) 2016-12-28 2018-07-05 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon
PT3328215T (pt) 2015-07-29 2021-08-03 Advanced Bionutrition Corp Composições probióticas estáveis secas para utilizações dietéticas especiais
JP6778051B2 (ja) * 2016-08-18 2020-10-28 沢井製薬株式会社 オセルタミビルリン酸塩含有医薬組成物
EP3562955A4 (en) 2016-12-28 2020-08-12 Ascus Biosciences, Inc. METHODS, APPARATUS AND SYSTEMS FOR THE ANALYSIS OF STRAINS OF MICRO-ORGANISMS OF HETEROGENEOUS COMMUNITIES COMPLEX WITH TRACEOR ANALYZES, DETERMINATION OF THEIR INTERACTIONS AND FUNCTIONAL RELATIONSHIPS, AND SUMMARY OF MICROBIAL SETS OF MICROBIAL SETS AND MICROBIAL SETS INCLUDING MICROBIAL SETS AND INGREDIENTS
WO2019069108A1 (en) * 2017-10-04 2019-04-11 Debreceni Egyetem SOLID GALENIC FORM, MOLDED, GASTRIC RETENTION AND EXTENDED RELEASE AND METHOD OF PREPARING THE SAME

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
US4489438A (en) * 1982-02-01 1984-12-18 National Data Corporation Audio response system
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
DE69331839T2 (de) 1992-01-29 2002-12-12 Takeda Chemical Industries, Ltd. Schnellösliche Tablette und ihre Herstellung
US5560921A (en) 1992-06-01 1996-10-01 The Procter & Gamble Company Chewable decongestant compositions
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
JP3722294B2 (ja) * 1993-02-23 2005-11-30 ワーナー−ランバート・コンパニー 実質的にアルコールを含有しない医薬組成物の製造方法
DE4317320A1 (de) 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5536264A (en) * 1993-10-22 1996-07-16 The Procter & Gamble Company Absorbent composites comprising a porous macrostructure of absorbent gelling particles and a substrate
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
KR100447096B1 (ko) 1995-02-27 2005-10-11 갈리드사이언스인코오퍼레이티드 바이러스성또는세균성뉴라미니다제의신규한선택적저해제
DK0976734T3 (da) 1995-02-27 2005-12-27 Gilead Sciences Inc Selektive inhibitorer af viral eller bakteriel neuraminidase
HUP9901716A3 (en) * 1995-06-07 2000-04-28 Quadrant Holdings Cambridge Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby
US5763483A (en) 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
ATE260646T1 (de) * 1996-04-16 2004-03-15 Novartis Consumer Health Sa Schnell zerfallende orale dosierungsform
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
CN1233169A (zh) * 1996-10-14 1999-10-27 弗·哈夫曼-拉罗切有限公司 一种粉末状制剂的制备工艺
US6004996A (en) 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JPH11137208A (ja) 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
ES2272066T3 (es) * 1998-04-09 2007-04-16 F. Hoffmann-La Roche Ag Proceso para la manufactura de particulas con tamaño de (sub)micras por disolucion de gas comprimido y surfactantes.
AU761351B2 (en) 1998-08-14 2003-06-05 Cheplapharm Arzneimittel Gmbh Pharmaceutical compositions containing lipase inhibitors
DE69916288T2 (de) * 1998-08-14 2005-03-24 F. Hoffmann-La Roche Ag Lipasehemmer und chitosan enthaltende arzneimittel
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
US6342249B1 (en) * 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
GB9900416D0 (en) 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
ATE400252T1 (de) 1999-02-10 2008-07-15 Pfizer Prod Inc Pharmazeutische feste dispersionen
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
IL153282A0 (en) * 2000-06-27 2003-07-06 Hoffmann La Roche Method for preparing a pharmaceutical composition

Similar Documents

Publication Publication Date Title
JP2007302683A5 (OSRAM)
JP2010501534A5 (OSRAM)
JP2010513478A5 (OSRAM)
JP2009502743A5 (OSRAM)
JP2009523771A5 (OSRAM)
JP2012255026A5 (OSRAM)
JP2006526031A5 (OSRAM)
JP2010536766A5 (OSRAM)
WO2010015567A3 (en) Controlled release formulations using intelligent polymers
JP2012517962A5 (OSRAM)
JP2008533007A5 (OSRAM)
JP2010535814A5 (OSRAM)
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
DE602006001365D1 (de) Kristallinform beta-d von Ivabradine-hydrochlorid, Verfahren zu dessen Herstellung und diesen enthaltende Pharmazeutische Zusammensetzung
WO2006011159A3 (en) Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
JP2010525073A5 (OSRAM)
IL188643A (en) Derivatives – n (troaryl) –1 – troarylalkyl – 1h – indole – 2– carboxamide, process for the production of derivatives, drug, pharmaceutical composition and use of derivatives for drug production.
WO2006082523A3 (en) Pharmaceutical sustained release composition of metformin
JP2011137005A5 (OSRAM)
JP2006517944A5 (OSRAM)
JP2010540547A5 (OSRAM)
WO2008011154A3 (en) Formulations for benzimidazolyl pyridyl ethers
WO2008006795A3 (en) Indole compounds
CL2007003130A1 (es) Uso de una formulacion de liberacion inmediata con un ingrediente activo seleccionado de pramipexol, hidrocloruro de pramipexol, dihidrocloruro de pramipexol monohidrato o una sal farmaceuticamente aceptable de este, para el tratamiento de la enferme
WO2011120903A3 (en) A fast dissolving pharmaceutical composition